MRI USED TO MONITOR EFFICACY OF EARLY TREATMENT OF R/R MS

被引：0
|
作者：
SMITH, ME
STONE, LA
FRANK, JA
ALBERT, P
MALONI, H
NAVEAU, I
PORTER, J
ARMSTRONG, M
MCFARLIN, DE
MCFARLAND, HF
机构：
来源：
NEUROLOGY | 1993年 / 43卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A183 / A183
页数：1
相关论文
共 50 条
  • [21] Antiemetic medication efficacy during EPOCH and R-EPOCH treatment
    Fleming, Megan K.
    Carr, Allison
    Li, Junan
    Lundberg, Jordan D.
    Rogers, Kerry A.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (07) : 1691 - 1698
  • [22] Efficacy of Viabahn (R) in the treatment of superficial femoral arterial occlusive disease
    Gonzalez Sanchez, S.
    Monux Ducaju, G.
    Serrano Hernando, F. J.
    Martinez Lopez, I.
    Martin Conejero, A.
    Hernando Rydings, M.
    ANGIOLOGIA, 2011, 63 (04): : 151 - 156
  • [23] Exosomal profiling should be used to monitor disease activity in MS patients: No
    Deltombe, Matthieu
    van Pesch, Vincent
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 (10) : 1206 - 1207
  • [24] CHRONIC HIGH-DOSE SYSTEMIC RECOMBINANT-ALPHA-2A-INTERFERON (R-ALPHA(2A)-IFN) IN RELAPSING REMITTING (R/R) MS - CLINICAL AND MRI EVALUATION
    CAVALLO, R
    DURELLI, L
    FERRI, R
    FERRIO, MF
    RIVA, A
    BRADAC, GB
    BERGAMASCO, B
    BERGAMINI, L
    NEUROLOGY, 1993, 43 (04) : A164 - A164
  • [25] Specific IgG antibody responses may be used to monitor leprosy treatment efficacy and as recurrence prognostic markers
    Duthie, M. S.
    Hay, M. N.
    Rada, E. M.
    Convit, J.
    Ito, L.
    Oyafuso, L. K. M.
    Manini, M. I. P.
    Goulart, I. M. B.
    Lobato, J.
    Goulart, L. R.
    Carter, D.
    Reed, S. G.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2011, 30 (10) : 1257 - 1265
  • [26] Specific IgG antibody responses may be used to monitor leprosy treatment efficacy and as recurrence prognostic markers
    M. S. Duthie
    M. N. Hay
    E. M. Rada
    J. Convit
    L. Ito
    L. K. M. Oyafuso
    M. I. P. Manini
    I. M. B. Goulart
    J. Lobato
    L. R. Goulart
    D. Carter
    S. G. Reed
    European Journal of Clinical Microbiology & Infectious Diseases , 2011, 30 : 1257 - 1265
  • [27] Indirect Comparison of Efficacy of Zanubrutinib Versus Acalabrutinib in the Treatment of Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL)
    Shah, Bijal
    Challagulla, Swetha
    Xu, Sheng
    Williams, Rhys
    Ren, Shijie
    Srivastava, Tushar
    Gautam, Raju
    Yang, Keri
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S516 - S517
  • [28] Week 96 Efficacy, Virology and Safety of Darunavir/r Versus Lopinavir/r in Treatment-Experienced Patients in TITAN
    Banhegyi, Denes
    Katlama, Christine
    da Cunha, Clovis Arns
    Schneider, Stefan
    Rachlis, Anita
    Workman, Cassy
    De Meyer, Sandra
    Vandevoorde, Ann
    Van de Casteele, Tom
    Tomaka, Frank
    CURRENT HIV RESEARCH, 2012, 10 (02) : 171 - 181
  • [29] Altered efficacy of AT1R-targeted treatment after spontaneous cancer cell-AT1R upregulation
    Ager, Eleanor I.
    Wen, Shu Wen
    Chan, Joyna
    Chong, Way W.
    Neo, Jaclyn H.
    Christophi, Christopher
    BMC CANCER, 2011, 11
  • [30] Altered efficacy of AT1R-targeted treatment after spontaneous cancer cell-AT1R upregulation
    Eleanor I Ager
    Shu Wen Wen
    Joyna Chan
    Way W Chong
    Jaclyn H Neo
    Christopher Christophi
    BMC Cancer, 11
12345